MicroRNA-337 participates in the progression of early-stage diabetic retinopathy by upregulating MAP3K12
Minerva Med
.
2022 Dec;113(6):1038-1040.
doi: 10.23736/S0026-4806.20.07035-4.
Epub 2020 Oct 6.
Authors
Qin Shi
1
,
Jianqiang Yu
2
,
Ping-An Andy Li
3
,
Xiaoli Lu
4
,
Weiling Wang
5
Affiliations
1
Department of Ophtalmology, Ningxia Medical University General Hospital, Yinchuan, China.
2
Pharmaceutical Sciences, Ningxia Medical University, Yinchuan, China.
3
Pharmaceutical Sciences, American North Carolina Central University, Durham, NC, USA.
4
Experimental Animal Center, Ningxia Medical University, Yinchuan, China.
5
Department of Ophtalmology, Ningxia Medical University General Hospital, Yinchuan, China - ling_ww123@163.com.
PMID:
33021359
DOI:
10.23736/S0026-4806.20.07035-4
No abstract available
MeSH terms
Diabetes Mellitus*
Diabetic Retinopathy* / etiology
Disease Progression
MicroRNAs*
Substances
MicroRNAs